相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiovascular toxicities associated with immune checkpoint inhibitors
Jiun-Ruey Hu et al.
CARDIOVASCULAR RESEARCH (2019)
Toxicities Associated With PD-1/PD-L1 Blockade
Daniel Y. Wang et al.
CANCER JOURNAL (2018)
Standardized End Point Definitions for Coronary Intervention Trials The Academic Research Consortium-2 Consensus Document
Hector M. Garcia-Garcia et al.
CIRCULATION (2018)
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
Karen A. Hicks et al.
CIRCULATION (2018)
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Syed S. Mahmood et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
Javid J. Moslehi et al.
LANCET (2018)
Chimeric Antigen Receptor Therapy
Carl H. June et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Takotsubo-Like Syndrome in Cancer Patients Treated With Immune Checkpoint Inhibitors
Stephane Ederhy et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Cardiovascular adverse events in immune checkpoint inhibitor clinical trials: A US Food and Drug Administration pooled analysis.
Laleh Amiri-Kordestani et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
Joe-Elie Salem et al.
LANCET ONCOLOGY (2018)
Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease
Alida L. P. Caforio et al.
EUROPEAN HEART JOURNAL (2017)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
Stephen J. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cardiovascular Toxicities Associated with Cancer Immunotherapies
Daniel Y. Wang et al.
CURRENT CARDIOLOGY REPORTS (2017)
Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies A Review
Weijuan Li et al.
JAMA ONCOLOGY (2017)
Smoldering myocarditis following immune checkpoint blockade
Timothy G. Norwood et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity
Marion Escudier et al.
CIRCULATION (2017)
Myocardial oedema in acute myocarditis detected by echocardiographic 2D myocardial deformation analysis
B. B. Logstrup et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2016)
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Douglas B. dbj Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cardiovascular Toxic Effects of Targeted Cancer Therapies
Javid J. Moslehi
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cardio-Oncology How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery
Andrew M. Bellinger et al.
CIRCULATION (2015)
Vascular and Metabolic Implications of Novel Targeted Cancer Therapies Focus on Kinase Inhibitors
Weijuan Li et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
Gerald P. Linette et al.
BLOOD (2013)
Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
Brian J. Cameron et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Modest Elevation in BNP in Asymptomatic Hypertensive Patients Reflects Sub-Clinical Cardiac Remodeling, Inflammation and Extracellular Matrix Changes
Dermot Phelan et al.
PLOS ONE (2012)
Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
Matthias G. Friedrich et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Noninvasive imaging in myocarditis
Hadi N. Skouri et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Nonheart failure-associated elevation of amino terminal pro-brain natriuretic peptide in the setting of sepsis
SL Bar et al.
CANADIAN JOURNAL OF CARDIOLOGY (2006)
Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis -: Comparison of different approaches
H Abdel-Aty et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Cardiovascular magnetic resonance assessment of human myocarditis - A comparison to histology and molecular pathology
H Mahrholdt et al.
CIRCULATION (2004)
Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction
R Witthaut et al.
INTENSIVE CARE MEDICINE (2003)
分享论文
